Cargando…
Drug resistance reversed by silencing LIM domain-containing protein 1 expression in colorectal carcinoma
The role of LIM domain-containing protein 1 (LIMD1) in the multidrug resistance of colorectal carcinoma (CRC) has not yet been established. The aim of the current study was to investigate the chemosensitivity of CRC multidrug-resistant (MDR) cells following the silencing of LIMD1. The MDR phenotypic...
Autores principales: | CHEN, ZHANGXING, ZHU, XIAOSAN, XIE, TAO, XIE, JUNPEI, QUO, KONG, LIU, XIANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081406/ https://www.ncbi.nlm.nih.gov/pubmed/25013501 http://dx.doi.org/10.3892/ol.2014.2155 |
Ejemplares similares
-
Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins
por: Bridge, Katherine S., et al.
Publicado: (2017) -
LIM-Domain-Binding Protein 1 Mediates Cell Proliferation and Drug Resistance in Colorectal Cancer
por: Zhu, Mo, et al.
Publicado: (2022) -
Analysis of the Drosophila Ajuba LIM protein defines functions for distinct LIM domains
por: Rauskolb, Cordelia, et al.
Publicado: (2022) -
LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
por: Xu, Beihui, et al.
Publicado: (2023) -
The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity
por: Mizunuma, H, et al.
Publicado: (2003)